Board of Directors

Robert J. Marshall, Jr.

Robert J. Marshall, Jr.

Chief Financial Officer andTreasurer, Lantheus Holdings, Inc.

Robert J. Marshall, Jr. brings to the Company more than 30 years of finance experience, including in M&A, capital markets and investor relations.

Currently, Bob is the Chief Financial Officer and Treasurer at Lantheus (NASDAQ: LNTH) since 2018.

Prior to joining Lantheus, Bob spent 16 years with Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a global medical device company with a leading position in musculoskeletal health. He held various senior leadership roles, including Vice President, Investor Relations and Corporate Treasurer, and most recently as Vice President, Americas Finance, for the U.S., Canadian and Latin American commercial markets.

Before joining Zimmer Biomet, Bob was employed with Brown & Williamson Tobacco, a subsidiary of British American Tobacco, p.l.c., in Louisville, Kentucky.

Bob holds a Master of Business Administration from Indiana University, South Bend, and a Bachelor of Business Administration in Finance from the University of Notre Dame. Bob also holds the CFA designation.

Robert VanHees

Robert VanHees

Chief Financial and Administrative Officer of WCG

Robert VanHees is the Chief Financial and Administrative Officer of WCG. In this dual role, Robert leads WCG global financial and human capital operations.

Robert joined WCG after spending five years at ProQuest, a global leader in education technology, where he served as President and Chief Financial Officer. Prior to ProQuest, he was with JLL Partners, a private equity firm, where he was an Operating Partner for five years, partnering with management to oversee strategy and operations of a variety of portfolio companies. He also served as CFO of the Learning Care Group, a childcare and early education provider. Earlier in his career, he was CFO for Corporate Express North America and Corporate Express Europe, served as a Controller, and held several roles in financial planning and analysis, treasury, and audit functions.

Robert holds a bachelor ’s degree in Accounting and Finance and a master’s degree in Business Administration and Management, both from Michigan State University.

B. Quentin Lilly

B. Quentin Lilly

Board Director / Consultant / Private Investor 

B. Quentin Lilly has extensive strategic, operational, financial, commercial, and acquisition-related experience and success across major worldwide markets and has a proven ability to build, grow and optimize worldwide teams, systems, infrastructure, customer base and scale manufacturing and supply-chain operations.

Quentin currently serves on the Board of Directors of Reconext, Inc., a global leader in the provision of after-market reprocessing, testing and reverse logistics services to the technology and communications sectors; and of Pacific Metals & Mfg. Co., a diversified investment holding company.

Prior to his role on the Board for Reconext, Inc., Quentin was at Technicolor Home Entertainment Services for 27 years. He served as President for over 20 years, was a member of the Executive Committee of publicly held Technicolor S.A. (now Vantiva S.A.), and served as Strategic Advisor, providing strategic, commercial, and operational support to executive management and the Board of Directors of Technicolor S.A. from March 2020 to March 2021.

Prior to his appointment as President, Quentin held several positions of increasing responsibility including Senior Vice President of Corporate Development and Chief Operating Officer.

Before joining Technicolor in 1994, Quentin spent approximately 10 years in the Corporate Finance/Capital Markets Groups at Smith Barney, and Crowell, Weedon & Co.

Quentin holds a Bachelor of Science degree in Business Administration, with a concentration in Finance, from California Polytechnic State University, San Luis Obispo.

Chris Yamamoto

Chris Yamamoto

Managing Partner of Event Capital Strategies 

Chris Yamamoto has over 20 years of mergers & acquisitions, strategy and investment experience in the medical technology, life sciences and industrials sectors having completed numerous transactions amounting to over $50B in value. 

Chris is the co-founder of Event Capital Strategies (ECS), a healthcare-focused investment fund. Prior to ECS, Chris spent over 10 years leading strategy & corporate development organizations at two publicly traded medical technology companies: Becton Dickinson (NYSE: BDX) and Bioventus (NASDAQ: BVS). Chris previously served as Vice President at The Blackstone Group and also worked at Fox Paine, Thoma Cressey, UBS Investment Bank and other institutions.

Chris holds a Bachelor of Arts degree in Economics from Williams College.